Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Cabioglu, N.; Karanlik, H.; Igci, A.; Uras, C.; Dulgeroglu, O.; Cakmak, G. Karadeniz; Sezer, A.; Gurleyik, G.; Tukenmez, M.; Bademler, S.; Muslumanoglu, M.; Ozkurt, E.; Yildirim, N.; Ugurlu, M. U.; Balbaloglu, H.; Emiroglu, S.; Ozmen, V.; Gulluoglu, B. M.

doi:10.1016/j.ejso.2025.109642

Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Date

2025

Authors

dc.identifier.doi

10.1016/j.ejso.2025.109642

dc.identifier.other

WOS:001434558500001

Publisher

ELSEVIER SCI LTD

DOI

10.1016/j.ejso.2025.109642

Keywords

Neoadjuvant systemic treatment , HER2\\-positive breast cancer , Triple\\-negative breast cancer , Recurrence , Node\\-positive breast cancer

URI

https://openaccess.acibadem.edu.tr/handle/11443/5191

Collections

WOS

Full item page

Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

Date

Authors

Journal Title

Journal ISSN

Volume Title

dc.identifier.issn

dc.identifier.doi

dc.identifier.other

dc.description.volume

dc.description.issue

Publisher

DOI

Abstract

Description

Keywords

Citation

URI

Collections

Endorsement

Review

Supplemented By

Referenced By